Form 8-K - Current report:
SEC Accession No. 0001558370-25-008525
Filing Date
2025-06-11
Accepted
2025-06-11 08:30:15
Documents
14
Period of Report
2025-06-11
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hrmy-20250611x8k.htm   iXBRL 8-K 47666
2 EX-99.1 hrmy-20250611xex99d1.htm EX-99.1 29639
3 GRAPHIC hrmy-20250611xex99d1001.jpg GRAPHIC 10901
  Complete submission text file 0001558370-25-008525.txt   214032

Data Files

Seq Description Document Type Size
4 EX-101.SCH hrmy-20250611.xsd EX-101.SCH 3298
5 EX-101.LAB hrmy-20250611_lab.xml EX-101.LAB 15928
6 EX-101.PRE hrmy-20250611_pre.xml EX-101.PRE 10081
16 EXTRACTED XBRL INSTANCE DOCUMENT hrmy-20250611x8k_htm.xml XML 4879
Mailing Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462
Business Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462 (484) 539-9800
Harmony Biosciences Holdings, Inc. (Filer) CIK: 0001802665 (see all company filings)

EIN.: 822279923 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39450 | Film No.: 251038839
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)